Stephen Mahoney
2023 - Signal Genetics
In 2023, Stephen Mahoney earned a total compensation of $12.5M as President, Chief Executive Officer and Director at Signal Genetics.
Compensation breakdown
| Bonus | $63,762 |
|---|---|
| Option Awards | $12,302,728 |
| Salary | $112,847 |
| Other | $184 |
| Total | $12,479,521 |
Mahoney received $12.3M in option awards, accounting for 99% of the total pay in 2023.
Mahoney also received $63.8K in bonus, $112.8K in salary and $184 in other compensation.
Rankings
In 2023, Stephen Mahoney's compensation ranked 12th out of 2,268 executives tracked by ExecPay. In other words, Mahoney earned more than 99.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12 out of 2,268 | 100th |
Division Services | 5 out of 353 | 99th |
Major group Health Services | 3 out of 41 | 93rd |
Industry group Medical And Dental Laboratories | 2 out of 21 | 91st |
Industry Medical Laboratories | 2 out of 21 | 91st |
Source: SEC filing on April 26, 2024.
Mahoney's colleagues
We found four more compensation records of executives who worked with Stephen Mahoney at Signal Genetics in 2023.
News
Signal Genetics CEO Scott Myers receives $36M in 2023
April 26, 2024
Dianthus Therapeutics Former President, Chief Financial and Operating Officer Stephen Mahoney's 2023 pay jumps 48% to $1.7M
April 11, 2024
Kiniksa Pharmaceuticals, Ltd. CEO Sanj Patel's 2019 pay falls 35% to $4.8M
April 28, 2020
Kiniksa Pharmaceuticals, Ltd. CEO Sanj Patel's 2018 pay jumps 389% to $7.3M
April 17, 2019